Management of antipsychotic treatment discontinuation and interruptions using model-based simulations | Zendy

Cynthia Samtani | Zendy; John J. Sheehan | Zendy; Fu | Zendy; Remmerie | Zendy; Sliwa | Zendy; Alphs | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations

Author(s) -

Cynthia Samtani,

John J. Sheehan,

Fu,

Remmerie,

Sliwa,

Alphs

Publication year - 2012

Publication title -

clinical pharmacology advances and applications

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.685

H-Index - 27

ISSN - 1179-1438

DOI - 10.2147/cpaa.s32735

Subject(s) - paliperidone , risperidone , discontinuation , paliperidone palmitate , pharmacokinetics , antipsychotic , medicine , pharmacology , atypical antipsychotic , schizophrenia (object oriented programming) , oral administration , plasma concentration , psychology , psychiatry

Medication nonadherence is a well described and prevalent clinical occurrence in schizophrenia. These pharmacokinetic model-based simulations analyze predicted antipsychotic plasma concentrations in nonadherence and treatment interruption scenarios and with treatment reinitiation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research